glp-1 cirrhosis Fatty Liver MASH Approval: What Patients Should Know GLP-1 Agonists Reduce Risk of
Description
Pharmaceutical companies are investing in next-generation analogues with extended half-lives, improved bioavailability, and once-weekly or even monthly dosing regimens
Not a Weight-Loss or Skin-Tightening Treatment Sofwave is not intended for weight loss, treating loose skin, or tightening skin
& Collet, X
)
Dahl, K
A phase 2 trial in 338 adults with obesity showed remarkable 24.2% mean weight loss ( vs
A landmark study published in March in The BMJ adds an interesting layer to that picture
